SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
-2.83%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$377M
AUM Growth
+$377M
(-2.5%)
Cap. Flow
-$5.69M
Cap. Flow
% of AUM
-1.51%
Top 10 Holdings %
Top 10 Hldgs %
73.26%
Holding
43
New
8
Increased
13
Reduced
9
Closed
13
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$21M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$15.3M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$10.3M |
| 4 |
SHPG
Shire pic
SHPG
|
$9.97M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$8.72M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$14.3M |
| 2 |
ELGX
Endologix Inc
ELGX
|
$13.9M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$13.5M |
| 4 |
Bausch Health
BHC
|
$12M |
| 5 |
Molina Healthcare
MOH
|
$10.5M |
Sector Composition
| 1 | Healthcare | 97.01% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sanofi
SNY
$121B
| $49.9M | 13.24% | 1,234,200 -200,400 | -14% | -$8.1M |
|
2
Eli Lilly
LLY
$657B
| $40.3M | 10.68% | 547,405 +112,905 | +26% | +$8.3M |
|
|
SHPG
3
DELISTED
Shire pic
SHPG
| $33.5M | 8.87% | 196,400 +58,500 | +42% | +$9.97M |
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $33.3M | 8.84% | 158,700 +100,200 | +171% | +$21M |
|
5
Elevance Health
ELV
$71.8B
| $31M | 8.22% | 215,500 -3,700 | -2% | -$532K |
|
|
ESRX
6
DELISTED
Express Scripts Holding Company
ESRX
| $30.7M | 8.15% | 447,001 +149,301 | +50% | +$10.3M |
|
|
TSRO
7
DELISTED
TESARO, Inc.
TSRO
| $19.1M | 5.07% | 142,300 +58,000 | +69% | +$7.8M |
|
|
MNK
8
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $15.3M | 4.05% | +306,500 | New | +$15.3M |
|
9
Halozyme
HALO
$8.56B
| $12.1M | 3.21% | 1,225,444 +674,900 | +123% | +$6.67M |
|
10
MiMedx Group
MDXG
$1.05B
| $11M | 2.93% | 1,245,550 -292,906 | -19% | -$2.6M |
|
11
Travere Therapeutics
TVTX
$1.56B
| $9.33M | 2.47% | 492,889 +22,100 | +5% | +$418K |
|
|
TVTY
12
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $8.72M | 2.31% | +383,200 | New | +$8.72M |
|
13
Centene
CNC
$14.3B
| $8.28M | 2.2% | +146,600 | New | +$8.28M |
|
14
Myriad Genetics
MYGN
$593M
| $8.25M | 2.19% | +495,100 | New | +$8.25M |
|
|
MNTA
15
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $8.01M | 2.12% | 531,898 -430,200 | -45% | -$6.47M |
|
16
Abbott
ABT
$231B
| $7.54M | 2% | +196,300 | New | +$7.54M |
|
|
AERI
17
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $7.15M | 1.9% | 188,900 +96,700 | +105% | +$3.66M |
|
|
CORI
18
DELISTED
Corium International, Inc.
CORI
| $6.4M | 1.7% | 1,576,766 -26,300 | -2% | -$107K |
|
|
FOMX
19
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $6.12M | 1.62% | 550,997 +27,600 | +5% | +$306K |
|
20
Esperion Therapeutics
ESPR
$448M
| $4.56M | 1.21% | +364,000 | New | +$4.56M |
|
|
NDRM
21
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $4.15M | 1.1% | 186,800 +15,500 | +9% | +$344K |
|
|
CNCE
22
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.12M | 1.09% | 400,588 -171,800 | -30% | -$1.77M |
|
23
Orthofix Medical
OFIX
$592M
| $4.03M | 1.07% | +111,375 | New | +$4.03M |
|
|
ARNA
24
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.67M | 0.71% | 1,877,491 +239,600 | +15% | +$340K |
|
|
ALDR
25
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $2.59M | 0.69% | 124,570 -172,100 | -58% | -$3.58M |
|